Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Anderson DC, Slater GE, Sherman R, Ettinger MG (1987) Evoked potentials to test a treatment of chronic multiple sclerosis. Arch Neurol 44:1232–1236
Andersson PB, Waubant E, Gee L, Goodkin DE (1999) Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability. Arch Neurol 56:1138–1142
Barkhof F, Filippi M, Miller DH et al. (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120:2059–2069
Bashir K, Whitaker JN (1999) Clinical and laboratory features of primary progressive and secondary progressive MS. Neurology 53:765–771
Beck RW, Cleary PA, Trobe JD et al. (1993) The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 329:1764–1769
Beer S, Rösler KM, Hess CW (1995) Diagnostic value of paraclinical tests in multiple sclerosis: Relative sensitivities and specifities for reclassification according to the Poser committee criteria. J Neurol Neurosurg Psychiatry 59:152–159
Brex PA, Ciccarelli O, O’Riordan JI, Sailer M, Thompson AJ, Miller DH (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med. 346:158–164
Brusa A, Jones SJ, Plant GT (2001) Long-term remyelination after optic neuritis. A 2-year visual evoked potential and psychophysical serial study. Brain 124:468–479
Chiappa KH, Ropper AH (1982) Evoked potentials in clinical medicine. N Engl J Med 306:1140–1150
Comi G, Filippi M, Martinelli V et al. (1993) Brain stem magnetic resonance imaging and evoked potential studies of symptomatic multiple sclerosis patients. Eur Neurol 33:232–237
Dalton CM, Brex PA, Miszkiel KA et al. (2002) Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 52:47–53
Davies MB, Williams R, Haq N, Pelosi L, Hawkins CP (1998) MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis. Neuroradiol 40:765–770
Edwards MK, Farlow MR, Stevens JC (1986) Cranial MR in spinal cord MS: diagnosing patients with isolated spinal chord symptoms. AJNR Am J Neuroradiol 7:1003–1005
Facchetti D, Mai R, Micheli A et al. (1997) Motor evoked potentials and disability in secondary progressive multiple sclerosis. Can J Neurol Sci 24:332–337
Farlow MR, Markand ON, Edwards MK, Stevens JC, Kolar OJ (1986) Multiple sclerosis: Magnetic resonance imaging, evoked responses, and spinal fluid electrophoresis. Neurology 36:828–831
Fierro B, Salemi G, Brighina F et al. (2002) A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis. Acta Neurol Scand 105:152–157
Filippini G, Comi G, Cosi V et al. (1994) Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis. J Neurol 241:132–137
Frederiksen J, Larsson H, Olesen J, Stigsby B (1991) MRI, VEP, SEP and biothesiometry suggest monosymptomatic acute optic neuritis to be a first manifestation of multiple sclerosis. Acta Neurol Scand 83:343–350
Frederiksen JL, Petrera J, Larsson HB, Stigsby B, Olesen J (1996) Serial MRI, VEP, SEP and biotesiometry in acute optic neuritis: Value of baseline results to predict the development of new lesions at one year follow up. Acta Neurol Scand 93:246–252
Fuhr P, Borggrefe-Chappuis A, Schindler C, Kappos L (2001) Visual and motor evoked potentials in the course of multiple sclerosis. Brain 124:2162–2168
Ghezzi A, Martinelli V, Torri V et al. (1999) Long-term follow-up of isolated optic neuritis: The risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J Neurol 246:770–775
Giang D, Grow V, Mooney C et al. (1994) Clinical diagnosis of multiple sclerosis. Arch Neurol 51:61–66
Gieser BS, Kurtzberg D, Vaughan HG et al. (1987) Trimodal evoked potentials compared with magnetic resonance imaging in the diagnosis of multiple sclerosis. Arch Neurol 44:281–284
Giovannoni G, Bever CT Jr (2003) Patients with clinically isolated syndromes suggestive of MS: Does MRI allow earlier diagnosis? Neurology 60:6–7
Gronseth GS, Ashman EJ (2000) Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1720–1725. Review
Halliday AM, McDonald WI, Mushin J (1973) Visual evoked responses in the diagnosis of multiple sclerosis. BMJ 4:661–664
Hess CW, Mills KR, Murray NMF, Schriefer TN (1987) Magnetic brain stimulation: central motor conduction studies in multiple sclerosis. Ann Neurol 22:744–752
Hume AL, Waxman SG (1988) Evoked potentials in suspected multiple sclerosis: Diagnostic value and prediction of clinical course. J Neurol Sci 83:191–210
IFNB Multiple Sclerosis Study Group (1995) Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial. Neurology 45:1277–1285
Iragui VJ, Wiederholt WC, Romine JS (1986) Serial recordings of multimodality evoked potentials in multiple sclerosis: A four year follow-up study. Can J Neurol Sci 13:320–326
Jacobs L, Kinkel PR, Kinkel WR (1986) Silent brain lesions in patients with isolated optic neuritis: A clinical and nuclear magnetic resonance imaging study. Arch Neurol 43:452–455
Japaridze G, Shakarishvili R, Kevanishvili Z (2002) Auditory brainstem, middle-latency, and slow cortical responses in multiple sclerosis. Acta Neurol Scand 106:47–53
Kandler RH, Jarratt JA, Davies-Jones GA et al. (1991) The role of magnetic stimulation as a quantifier of motor disability in patients with multiple sclerosis. J Neurol Sci 106:31–34
Kappos L, Moeri D, Radue EW et al. (1999) Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: A meta-analysis. Gadolinium MRI Meta-analysis Group. Lancet 353:964–969
Kempster PA, Balla JI, Iansek R, Dennis PM (1987) Value of visual evoked response and oligoclonal bands in cerebrospinal fluid in diagnosis of spinal multiple sclerosis. Lancet I:769–771
Khoshbin S, Hallett M (1981) Multimodality evoked potentials and blink reflex in multiple sclerosis. Neurology 31:138–144
Kjaer M (1983) Evoked potentials. With special reference to the diagnostic value in multiple sclerosis. Acta Neurol Scand 67:67–89
Lee K, Hashimoto S, Hooge J et al. (1991) Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: A prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 41:657–660
Martinelli V, Comi G, Filippi M et al. (1991) Paraclinical tests in acute-onset optic neuritis: Basal data and results of a short follow-up. Acta Neurol Scand 84:231–236
Matthews WB, Wattam-Bell JRB, Pountney E (1982) Evoked potentials in the diagnosis of multiple sclerosis: A follow up study. J Neurol Neurosurg Psychiatry 45:303–307
Matthews WB (1978) Somatosensory evoked potentials in retrobulbar neuritis. Lancet 1(8061):443
Matthews WB, Wattam-Bell JR, Pountney E (1982) Evoked potentials in the diagnosis of multiple sclerosis: A follow up study. J Neurol Neurosurg Psychiatry 45:303–307
Mayr N, Baumgartner C, Zeitlhofer J, Deecke L (1991) The sensitivity of transcranial cortical magnetic stimulation in detecting pyramidal tract lesions in clinically definite multiple sclerosis. Neurology 41:566–569
McAlpine D, Lumsden CE, Acheson ED (1972) Multiple sclerosis: A reappraisal. Livingstone, Edinburgh
McDonald WI, Compston A, Edan G et al. (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127
McFarland HF, Barkhof F, Antel J, Miller DH (2002) The role of MRI as a surrogate outcome measure in multiple sclerosis. Mult Scler 8:40–51
Miller DH, Ormerod IE, McDonald WI et al. (1988) The early risk of multiple sclerosis after optic neuritis. J Neurol Neurosurg Psychiatry 51:1569–1571
O’Connor P, Marchetti P, Lee L, Perera M (1998) Evoked potential abnormality scores are a useful measure of disease burden in relapsing-remitting multiple sclerosis. Ann Neurol 44:404–407
O’Riordan JI, Thompson AJ, Kingsley DP et al. (1998) The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 121:495–503
Optic Neuritis Study Group (1997) The 5-year risk of MS after after optic neuritis: Experience of the optic neuritis treatment trial. Neurology 49:1404–1413
Ormerod IEC, Bronstein A, Rudge P et al. (1986a) Magnetic resonance imaging in clinically isolated lesions of the brain-stem. J Neurol Neurosurg Psychiatry 49:737–743
Ormerod IEC, McDonald WI, Boulay GH du et al. (1986b) Disseminated lesions at presentation in patients with optic neuritis. J Neurol Neurosurg Psychiatry 49:124–127
Ormerod IEC, Miller DH, MacDonald WI et al. (1987) The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantiative study. Brain 110:1579–1616
Poser CM (1987) Diagnostic criteria for multiple sclerosis: An addendum. Ann Neurol 17:773
Poser CM, Paty DW, Scheinberg L et al. (1983) New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 13:227–231
Poser CM, Brinar VV (2001) Problems with diagnostic criteria for multiple sclerosis. Lancet 358:1746–1747
Ravnborg M, Liguori R, Christiansen P, Larsson H, Soelberg P (1992) The diagnostic reliability of magnetically evoked motor potentials in multiple sclerosis. Neurology 42:1296–1301
Rodriguez M, Siva A, Cross SA, O’Brien PC, Kurland LT (1995) Optic neuritis: A population-based study in Olmsted County, Minnesota. Neurology 45(2):244–250
Rossini PM, Zarola F, Floris R et al. (1989) Sensory (VEP, BAEP, SEP) and motor-evoked potentials, liquoral and magnetic resonance findings in multiple sclerosis. Eur Neurol 29:41–47
Sailer M, O’Riordan JI, Thompson AJ et al. (1999) Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. Neurology 52:599–606
Salle JY, Hugon J, Tabaraud F et al. (1992) Improvement in motor evoked potentials and clinical course post-steroid therapy in multiple sclerosis. J Neurol Sci 108:184–188
Sater RA, Rostami AM, Galetta S, Farber RE, Bird SJ (1999) Serial evoked potential studies and MRI imaging in chronic progressive multiple sclerosis. J Neurol Sci 171:79–83
Schmierer K, Irlbacher K, Grosse P, Roricht S, Meyer BU (2002) Correlates of disability in multiple sclerosis detected by transcranial magnetic stimulation. Neurology 59:1218–1224
Simon JH, Jacobs LD, Campion M et al. (1998) Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. Ann Neurol 43:79–87
Soustiel JF, Hafner H, Chistyakov AV et al. (1996) Brain-stem trigeminal and auditory evoked potentials in multiple sclerosis: physiological insights. Electroencephalogr Clin Neurophysiol 100:152–157
Staffen W, Trinka E, Ladurner G (1993) Die diagnostische Wertigkeit der Kernspintomographie, der multimodal evozierten Potentiale und der Liquoruntersuchung bei multipler Sklerose. Nervenarzt 64:226–232
Thompson AJ, Polman CH, Miller DH et al. (1997) Primary progressive multiple sclerosis. Brain 120:1085–1096
Thompson AJ, Montalban X, Barkhof F et al. (2000) Diagnostic criteria for primary progressive multiple sclerosis: A position paper. Ann Neurol 47:831–835
Tintoré M, Rovira A, Martinez MJ et al. (2000) Isolated demyelinating syndromes: Comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol 21:702–706
Tintoré M, Rovira A, Rio J et al. (2003) New diagnostic criteria for multiple sclerosis: Application in first demyelinating episode. Neurology 60:27–30
Trojaborg W, Boettcher J, Saxtrup O (1981) Evoked potentials and immunoglobulin abnormalities in multiple sclerosis. Neurology 31:866–871
Truyen L, van Waesberghe JH, van Walderveen MA et al. (1996) Accumulation of hypointense lesions (»black holes«) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 47:1469–1476
Turano G, Jones S, Miller D, du Boulay G, Kakigi R, McDonald W (1991) Correlation of SEP abnormalities with brain and cervical cord MRI in multiple sclerosis. Brain 114:663–681
Uldry P-A, Regli F, Uské A (1993) Magnetic resonance imaging in patients with multiple sclerosis and spinal cord involvement: 28 cases. J Neurol 240:41–45
Waxman SG (1988) Clinical course and electrophysiology of multiple sclerosis. Adv Neurol 47:157–184
Wolinsky JS; PROMiSe Study Group (2003) The diagnosis of primary progressive multiple sclerosis. J Neurol Sci 206:145–152
Yetkin FZ, Haughton VM, Paoke RA, Fischer ME, Rao SM (1991) Multiple sclerosis: Specificity of MR for the diagnosis. Radiology 178:447–456
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Haarmeier, T., Dichgans, J. (2005). Die Wertigkeit der evozierten Potenziale in der Diagnostik der multiplen Sklerose. In: Evozierte Potenziale. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26659-3_5
Download citation
DOI: https://doi.org/10.1007/3-540-26659-3_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-01773-8
Online ISBN: 978-3-540-26659-4
eBook Packages: Medicine (German Language)